Basic Information
Basic information for C21orf62-AS1-213-48aa
Peptide Name C21orf62-AS1-213-48aa
Genome Position chr21:32788663-32788701,32796939-32797043[+]
Species Human
Peptide Sequence MTLNVEEWATAWKVLILLEAAVEEEKRSEEKRILVCGTCGTRSSQKNL
Peptide Length 48
Unique No (C21orf62-AS1-201-48aa,C21orf62-AS1-203-48aa,C21orf62-AS1-206-48aa)
Grand Average of Hydropathicity -0.2646
Relative Molecular Mass 6311.13
Experimental Evidences 1:m6A
lncRNA ID/Name ENSG00000205930;C21orf62-AS1
Transcript ID/Name ENST00000669746;C21orf62-AS1-213
Transcript Length 1704
Coding Ability 0.3674
DNA Sequence Corresponding to Peptide ATGACTCTCAATGTTGAAGAATGGGCTACTGCATGGAAGGTGCTGATCCTTTTAGAGGCAGCCGTGGAAGAGGAAAAGAGATCAGAAGAGAAAAGGATATTGGTTTGCGGAACATGTGGGACAAGAAGTTCCCAGAAGAATTTG
Experimental Evidences
   m6A
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :